Jump Financial’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.27M | Buy |
+352,155
| New | +$6.27M | 0.07% | 343 |
|
|
2025
Q1 | – | Sell |
-176,252
| Closed | -$5.25M | – | 1876 |
|
|
2024
Q4 | $5.25M | Buy |
176,252
+39,106
| +29% | +$1.17M | 0.11% | 245 |
|
|
2024
Q3 | $2.14M | Buy |
137,146
+25,786
| +23% | +$403K | 0.04% | 492 |
|
|
2024
Q2 | $1.91M | Sell |
111,360
-998
| -0.9% | -$17.1K | 0.04% | 574 |
|
|
2024
Q1 | $1.76M | Buy |
112,358
+8,734
| +8% | +$137K | 0.05% | 510 |
|
|
2023
Q4 | $1.55M | Buy |
+103,624
| New | +$1.55M | 0.05% | 497 |
|
|
2023
Q2 | – | Sell |
-37,719
| Closed | -$2.27M | – | 2051 |
|
|
2023
Q1 | $2.27M | Buy |
+37,719
| New | +$2.27M | 0.09% | 330 |
|
|
2022
Q4 | – | Sell |
-16,622
| Closed | -$1.26M | – | 1891 |
|
|
2022
Q3 | $1.26M | Buy |
+16,622
| New | +$1.26M | 0.05% | 531 |
|
|
2022
Q2 | – | Sell |
-46,000
| Closed | -$3.81M | – | 1895 |
|
|
2022
Q1 | $3.81M | Buy |
46,000
+36,876
| +404% | +$3.06M | 0.16% | 129 |
|
|
2021
Q4 | $685K | Sell |
9,124
-17,876
| -66% | -$1.34M | 0.04% | 520 |
|
|
2021
Q3 | $3.14M | Buy |
+27,000
| New | +$3.14M | 0.23% | 49 |
|
|
2021
Q2 | – | Sell |
-9,436
| Closed | -$1.25M | – | 1306 |
|
|
2021
Q1 | $1.25M | Buy |
9,436
+4,176
| +79% | +$552K | 0.12% | 188 |
|
|
2020
Q4 | $910K | Buy |
5,260
+1,788
| +51% | +$309K | 0.15% | 176 |
|
|
2020
Q3 | $386K | Buy |
+3,472
| New | +$386K | 0.08% | 411 |
|